© 1995 American Heart Association, Inc.
Articles |
Apolipoprotein B and E Basic Amino Acid Clusters Influence Low-Density Lipoprotein Association with Lipoprotein Lipase Anchored to the Subendothelial Matrix
From the Department of Atherosclerosis Therapeutics, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Co, Ann Arbor, Mich (U.S., B.J.A., E.F., J.W., C.L.B.); University of Ottawa (Ontario, Canada) Heart Institute (Y.L.M.); Gladstone Institute of Cardiovascular Disease, Cardiovascular Research Institute, Department of Pathology, University of California–San Francisco (K.H.W.); and St Michael's Hospital, Division of Endocrinology and Metabolism, Toronto, Ontario, Canada (R.A.H.).
Correspondence to Uday Saxena, PhD, Atherosclerosis Therapeutics, Parke-Davis Pharmaceutical Research, 2800 Plymouth Rd, Ann Arbor, MI 48105.
Abstract Lipoprotein accumulation in the subendothelial matrix is an important step in atherogenesis. We have previously shown that addition of lipoprotein lipase (LPL) markedly increased binding of apolipoprotein B (apoB)–containing lipoproteins to an endothelial cell–derived matrix, and this enhanced lipoprotein binding was inhibited by apoE. In the present studies we examined the role of various regions of apoB in the binding of LDL to LPL-containing endothelial cell matrix and the ability of various apoE domains to decrease lipoprotein retention. We studied three apoB epitope-specific monoclonal antibodies for their ability to block the binding of 125I-LDL to LPL-containing matrix. Of these, monoclonal antibody 4G3, which recognizes an arginine-containing epitope in apoB, was the most effective in reducing LDL binding. Chemical modification of LDL apoB lysines or arginines markedly reduced the ability of the lipoprotein to block the binding of 125I-LDL to LPL-containing matrix, suggesting that apoB positively charged amino acids are involved in the interaction. Furthermore, polyarginine or polylysine markedly decreased 125I-LDL binding to LPL-containing matrix, whereas polyleucine was ineffective. These data suggest that apoB positively charged regions are important in LDL binding. To explore the role of charge modifications on apoE by single arginine-cysteine interchanges, we examined the effects of the three major human apoE isoforms (apoE2, apoE3, and apoE4). ApoE3 was the most effective in decreasing 125I-LDL retention, followed by apoE4; apoE2 was the least effective. Similarly, apoE2-containing HDL was much less effective than apoE3-containing HDL in decreasing 125I-LDL retention. Therefore, both cysteine for arginine substitutions at amino acids 112 and 158, known to markedly reduce apoE binding to the LDL receptors, also had significant effects on the ability of this apoE isoform to displace LDL bound to LPL. Two peptides generated by thrombin cleavage of apoE3 both were able to decrease 125I-LDL binding, indicating the presence of multiple sites within apoE that could participate in the inhibitory effect. We conclude that positively charged regions on apoB are responsible for the binding of LDL to LPL-containing matrix and that similar regions of positive charge in apoE allow it to compete and decrease the retention of LDL.
Key Words: lipoprotein lipase • LDL • subendothelial matrix • apo E • lipoprotein retention
This article has been cited by other articles:
 |
|
 |
|
  I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tryggvason and J. Patrakka Thin Basement Membrane Nephropathy J. Am. Soc. Nephrol., March 1, 2006; 17(3): 813 - 822. [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Medh, G. L. Fry, S. L. Bowen, S. Ruben, H. Wong, and D. A. Chappell Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism J. Lipid Res., November 1, 2000; 41(11): 1858 - 1871. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, and G. Camejo Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans: Potential Contribution to Atherogenesis Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1011 - 1017. [Abstract] [Full Text]
|
|
|
|
|
|
U. Olsson, G. Camejo, E. Hurt-Camejo, K. Elfsber, O. Wiklund, and G. Bondjers Possible Functional Interactions of Apolipoprotein B-100 Segments That Associate With Cell Proteoglycans and the ApoB/E Receptor Arterioscler Thromb Vasc Biol, January 1, 1997; 17(1): 149 - 155. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. C.N. Rensen and T. J.C. van Berkel Apolipoprotein E Effectively Inhibits Lipoprotein Lipase-mediated Lipolysis of Chylomicron-like Triglyceride-rich Lipid Emulsions in Vitro and in Vivo J. Biol. Chem., June 21, 1996; 271(25): 14791 - 14799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Auerbach, C. L. Bisgaier, J. Wölle, and U. Saxena Oxidation of Low Density Lipoproteins Greatly Enhances Their Association with Lipoprotein Lipase Anchored to Endothelial Cell Matrix J. Biol. Chem., January 19, 1996; 271(3): 1329 - 1335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Boren, A. Lookene, E. Makoveichuk, S. Xiang, M. Gustafsson, H. Liu, P. Talmud, and G. Olivecrona Binding of Low Density Lipoproteins to Lipoprotein Lipase Is Dependent on Lipids but Not on Apolipoprotein B J. Biol. Chem., July 13, 2001; 276(29): 26916 - 26922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Klezovitch, M. Formato, G. M. Cherchi, K. H. Weisgraber, and A. M. Scanu Structural Determinants in the C-terminal Domain of Apolipoprotein E Mediating Binding to the Protein Core of Human Aortic Biglycan J. Biol. Chem., June 16, 2000; 275(25): 18913 - 18918. [Abstract] [Full Text] [PDF]
|
|